Tonix gives update on development of its single-dose live attenuated virus vaccine candidate for…
TNX-801 is a live replicating attenuated vaccine candidate based on horsepox that is believed to provide immune protection with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Tonix Pharmaceuticals
Tonix Pharmaceuticals and Southern Research COVID-19 vaccine provides a novel vector
As horsepox virus may have been accidentally extirpated there has most likely been no previous exposure to the vector, and any…